HLA-DRB1

Chr 6MultiAD

major histocompatibility complex, class II, DR beta 1

Also known as: DRB1, HLA-DR1B, HLA-DRB, SS1

HLA-DRB1 belongs to the HLA class II beta chain paralogs. The class II molecule is a heterodimer consisting of an alpha (DRA) and a beta chain (DRB), both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells. The beta chain is approximately 26-28 kDa. It is encoded by 6 exons. Exon one encodes the leader peptide; exons 2 and 3 encode the two extracellular domains; exon 4 encodes the transmembrane domain; and exon 5 encodes the cytoplasmic tail. Within the DR molecule the beta chain contains all the polymorphisms specifying the peptide binding specificities. Hundreds of DRB1 alleles have been described and some alleles have increased frequencies associated with certain diseases or conditions. For example, DRB1*1302 has been related to acute and chronic hepatitis B virus persistence. There are multiple pseudogenes of this gene. [provided by RefSeq, Jul 2020]

Primary Disease Associations & Inheritance

{Multiple sclerosis, susceptibility to, 1}MIM #126200
Multi
{Sarcoidosis, susceptibility to, 1}MIM #181000
AD
UniProtSarcoidosis 1
UniProtRheumatoid arthritis
49
ClinVar variants
7
Pathogenic / LP
0.00
pLI score
4
Active trials
Clinical SummaryHLA-DRB1
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
7 Pathogenic / Likely Pathogenic· 10 VUS of 49 total submissions
💊
Clinical Trials
4 active or recruiting trials — potential therapeutic options may be available

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?LOEUF (Loss-of-function Observed/Expected Upper bound Fraction) is the upper bound of the 90% CI for LoF OE — the preferred gnomAD v4 metric. Lower = more intolerant to LoF. LOEUF < 0.35 = highly constrained.
1.16LOEUF
pLI 0.001
Z-score 1.23
OE 0.59 (0.321.16)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?Missense Z-score: standard deviations fewer missense variants observed vs. expected. Z > 3.09 (p < 0.001) = gene does not tolerate missense variation. OE missense < 0.6 is also considered constrained.
1.18Z-score
OE missense 0.70 (0.580.84)
84 obs / 120.4 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?Shaded band = 90% confidence interval. Vertical tick = point estimate. Grey threshold line = gnomAD constraint cutoff for that variant class.
LoF OE?Ratio of observed to expected LoF variants. Upper CI bound (LOEUF) ≤ 0.35 = strong LoF constraint signal.0.59 (0.321.16)
00.351.4
Missense OE?Ratio of observed to expected missense variants. OE ≤ 0.6 = fewer missense variants than expected by chance.0.70 (0.580.84)
00.61.4
Synonymous OE?Control metric — synonymous variants are largely neutral and expected near OE = 1.0. Significant deviation may indicate annotation issues.0.81
01.21.6
LoF obs/exp: 6 / 10.2Missense obs/exp: 84 / 120.4Syn Z: 1.06

ClinVar Variant Classifications

49 submitted variants in ClinVar

Classification Summary

Pathogenic5
Likely Pathogenic2
VUS10
Likely Benign21
Benign11
5
Pathogenic
2
Likely Pathogenic
10
VUS
21
Likely Benign
11
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
1
4
0
5
Likely Pathogenic
1
0
1
0
2
VUS
0
5
5
0
10
Likely Benign
6
3
2
10
21
Benign
2
3
6
0
11
Total912181049

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

HLA-DRB1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

OMIM — Genotype-Phenotype Relationships

1 OMIM entry

{Multiple sclerosis, susceptibility to, 1}

MIM #126200

Molecular basis of disorder known

Multifactorial

{Sarcoidosis, susceptibility to, 1}

MIM #181000

Molecular basis of disorder known

Autosomal dominant
Clinical Literature
Landmark / reviewRecent case evidence
Key Publications
Landmark & review papers · by relevance
PubMed
Genetics of neurosarcoidosis.
Hardin A et al.·J Neuroimmunol
2022Review
Genetics of sarcoidosis.
Spagnolo P et al.·Clin Dermatol
2007Review
Poststreptococcal reactive arthritis.
Shulman ST et al.·Curr Opin Rheumatol
2002Review
The Role of HLA in MS Susceptibility and Phenotype.
Greer JM·Curr Top Behav Neurosci
2015Review
Genetic Biomarkers for Statin-Induced Myopathy.
Prieto-Peña D et al.·Int J Mol Sci
2025
HLA associations and Löfgren's syndrome.
Grunewald J·Expert Rev Clin Immunol
2012Review
Top 10 resultsSearch PubMed ↗